Omics-based exploration of biomarkers and therapeutic targets in olfactory neuroblastoma.

Overview

1. State Key Laboratory of Mechanism and Quality of Chinese Medicine, University of Macau, Macao, China
2. Centre for Pharmaceutical Regulatory Sciences, Institute of Chinese Medical Sciences, University of Macau, Macao, China
3. Department of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Macao, China
4. School of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province China

Abstract

Introduction: Olfactory Neuroblastoma (ONB) is a rare and aggressive malignant tumor with a complex, heterogeneous pathogenesis. Although various omics studies have been conducted for ONB recently, there is still no omics evidence summary for ONB. Therefore, this study systematically reviews and synthesizes evidence across multiple omics layers for identifying biomarkers and therapeutic targets of ONB, aiming to advance the translation of molecular insights into clinical applications, including subtype classification, targeted therapy, and drug development.

Methods: We conducted a systematic review following the PRISMA 2020 guidelines and registered with PROSPERO (ID: CRD420251128889). Five databases were searched up to 31st May 2025 for original studies that applied single- or multi-omics analyses to ONB. Risk of bias was assessed using the JBI Case Series Checklist.

Results: A total of 24 studies were included, covering genomics (11/24), transcriptomics (5/24), proteomics (1/24), and multi-omics integration (7/24). Genomic studies identified recurrent mutations (e.g., TP53, IDH2), chromosomal alterations (e.g., 1p, 3p, 13q), and pathway-level changes (e.g., PI3K/AKT/mTOR, chromatin remodeling). Transcriptomic studies revealed Basal, Neural, and Mesenchymal subtypes, with NEUROD1 and EZH2 serving as key biomarkers. For proteomics, one immunohistochemistry-focused study reports markers such as Trk proteins and GRP78. Multi-omics studies integrated subtyping, tumor-origin hypotheses, and immune landscape characterization, supporting biomarkers such as IDH2, NEUROD1, and EZH2, and highlighting heterogeneity. However, there is very limited functional validation (only one study) and limited AI/ML usage (two studies), despite their potential to assist with small cohorts and multimodal integration.

Conclusion: This review consolidates current evidence on candidate biomarkers and therapeutic targets for ONB, highlighting the vital role of omics-based approaches in elucidating its molecular mechanisms. To advance the field, future research should focus on standardizing methods, validating findings in larger, more diverse groups, and integrating multi-omics techniques with AI–driven analyses to enhance diagnostic precision and develop targeted treatments.

Supplementary Information: The online version contains supplementary material available at 10.1007/s12672-026-05299-0.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• geo:GSE118995, at NCBI GEO; found in the resources table

Data availability

No datasets were generated or analysed during the current study.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 6 authors, 5 keywords, 1 funder, 45 references.

Cite

This paper

Deng, N., Chen, Z., Ung, C. O. L., Lai, Y., Song, M., & Hu, H. (2026). Omics-based exploration of biomarkers and therapeutic targets in olfactory neuroblastoma. Discover oncology, 17(1), 1090. https://doi.org/10.1007/s12672-026-05299-0

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1212/wnl.0000000000218031

Acute Kidney Injury and Risk of Adverse Neurocognitive Outcomes: A Systematic Review and Meta-Analysis.

Journal: Neurology

In common: clinical / translational, other condition, 1 reference

[2] doi:10.1186/s12984-026-01991-y

Multimodal colour modulation for cognitive enhancement in intelligent rehabilitation: a systematic review and translational guidance.

Journal: Journal of neuroengineering and rehabilitation

In common: clinical / translational, 1 reference

[3] doi:10.1080/20008066.2026.2640736

Biological and neurocognitive correlates of comorbid post-traumatic stress disorder and alcohol use disorder: a systematic review.

Journal: European journal of psychotraumatology

In common: other condition, 1 reference

[4] doi:10.1162/imag.a.1292 [code]

Assessing adverse effects and unspecific effects of transcutaneous spinal direct current stimulation (tsDCS).

Journal: Imaging neuroscience (Cambridge, Mass.)

In common: 1 reference

[5] doi:10.3389/fpsyt.2026.1803658

Comparative meta-analysis of task-related functional brain abnormalities in nonsuicidal self-injury and suicide attempt.

Journal: Frontiers in psychiatry

In common: 1 reference

[6] doi:10.1111/psyp.70352 [code]

Preprocessing on the Go: Practices in Gait-Related Mobile EEG.

Journal: Psychophysiology

In common: 1 reference

[7] doi: [code]

Neural Correlates of Inhibitory Control in Impulsivity Traits in Non-Ecological Human–Computer Tasks: An ALE Meta-Analysis

Journal: Brain sciences

In common: 1 reference

[8] doi:10.1162/imag.a.1281

Syntactic processing engages the semantic control network.

Journal: Imaging neuroscience (Cambridge, Mass.)

In common: 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.